Altria's Discipline Catching Up: Volume Decline Moderates, On! PLUS Ramps

Q2 2026: Cigarette declines ease to -4.5% (adj.), on! PLUS goes national 90%+ ACV, and management raises low-end EPS guidance — all while the consumer stays squeezed.

MO · Earnings Call · 2026-07-30

The Moderation Becomes a Trend

Altria's second quarter 2026 earnings call had one message that stood apart from the noise: the secular decline in U.S. cigarette volume is finally easing, and the company is taking credit for a disciplined response to a squeezed consumer. Management estimated that industry cigarette volumes declined ~5% in both Q2 and H1 2026 — a fourth consecutive quarter of moderated declines. The driver, CEO Sal Mancuso explained, is not an improving consumer but rather a “moderation in cross-category movement” as enforcement against illicit flavored disposables gains traction and those products saturate. Volume declines are now being lapped against tougher prior-year comparisons, allowing PM USA to post a modest 3.2% reported decline and an adjusted -4.5% (after trade inventory adjustments). This trend was already visible in Q1 2026, when Sal said on the prior call, “What you saw was stronger volume performance, and that's primarily driven in the smokeable category by a moderation of the cross-category movement that I talked about in my opening remarks.” — Salvatore Mancuso, Chief Financial Officer (CFO) · 2026-04-30 Now, it is firming into a pattern. The question is whether this is a structural shift or a temporary reprieve. Altria's data suggest that the number of adult vapers has plateaued at ~20 million, down slightly from a year ago, and that disposable e-vapor consumers are beginning to decline. “While illicit-flavored disposable products remain prevalent, signs of moderating growth continued in the second quarter, and we're beginning to see this reflected in the consumer data.” — Salvatore Mancuso, Chief Executive Officer (CEO) · 2026-07-30

On! PLUS and the Premium Push

The more exciting narrative is in oral nicotine. On! PLUS — the larger, softer-pouch iteration that offers higher nicotine strengths — has now reached 120,000 stores, covering roughly 90% of nicotine product volume. “We're really pleased with the on! PLUS launch. It's in about 120,000 stores. So it covers about 90% of the nicotine product volume.” — Salvatore Mancuso, Chief Executive Officer (CEO) · 2026-07-30 The brand's retail share reached 8.6%, up 0.8 share points sequentially, and management is positioning on! PLUS as a premium product, with a 12-milligram national expansion planned for Q3 and flavor extensions (Blueberry Mint, Mango Pineapple) coming in Q4. national expansion is being paired with a new retail trade program that secures premium visibility — a critical step as competitors like Zyn intensify flavor innovation and promotional spend. On the combustible side, PM USA's discount brand Basic continues to capture share in the deep-discount segment, adding 2.3 points year-over-year, while Marlboro held its premium share at 59.6%. The portfolio approach — leveraging RGM tools to protect Marlboro's profitability while using Basic as a defensive shield — is paying off. Marlboro Cowboy Cut, launched to celebrate the 250th anniversary, is another RGM lever to give value-seeking premium smokers a reason to stay within the family. As Sal put it, “It really leverages Marlboro's American heritage. And at the same time, it engages with more value-sensitive Marlboro smokers and premium smokers who are seeking value at a time when the economic environment is difficult for those consumers.” — Salvatore Mancuso, Chief Executive Officer (CEO) · 2026-07-30

The Duty Drawback and the Balance Sheet

The second quarter also brought a key financial update on the double-duty-drawback program, which allows Altria to reduce federal excise tax paid on cigarettes that are exported and later imported. The benefit was flat sequentially due to timing of credit applications and inventory staging. CFO Heather Newman clarified, “Really, what you're seeing is a timing factor. And so there are 2 components to that, why that's not truing up to the FET credit. One is the time in terms of when we apply for that credit. The other is just staging of products, some inventory movement, and that's why that's not perfectly lining up.” — Heather Newman, Chief Financial Officer (CFO) · 2026-07-30 Management expects export volumes to increase in H2, with a more balanced benefit across Q3 and Q4. The program is capital intensive — CapEx jumped 145% y/y to $93M in Q1 2026 — but the payback is swift. On the January call, former CEO Billy Gifford explained the rationale: “we're not going to be at a competitive disadvantage regarding that. We will continue to look for opportunities to expand.” — Billy Gifford, Chief Executive Officer · 2026-01-29 Meanwhile, Altria's pricing power remains intact. Gross margin reached 64.6% in the latest reported quarter (Q1 2026), up 2.8 points year-over-year, a direct result of strong Marlboro net pricing and a favorable mix shift from premium volumes. Gross margin climbed to 64.6% in Q1 2026, confirming that disciplined RGM and Basic's defensive role are not eroding overall profitability.

Guidance: A Narrow High

Reflecting a strong first half, management raised the low end of full-year 2026 adjusted EPS guidance to a range of $5.61–$5.72 (3.5%–5.5% growth). Heather stated,

As we've discussed this morning, our business performed extremely well during the first half of the year. As a result, we are raising the lower end of our full year 2026 guidance. We now expect to deliver adjusted diluted EPS in a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from a base of $5.42 in 2025.
Heather Newman, Chief Financial Officer (CFO) · 2026-07-30

The move underscores confidence that volume moderation, on! PLUS momentum, and the duty-drawback tailwind will together offset ongoing consumer strain. Altria's story this quarter is one of steady execution within a mature industry. The company isn't breaking new ground; it's tightening its grip on a familiar playbook: moderate declines, defend premium share, milk pricing power, and prudently invest in a smoke-free future. The Tobacco harm reduction narrative is real, but the near-term earnings power comes from disciplined cost and pricing management. With the stock hovering around $74, just 11.8% below its July peak, investors are being rewarded for patience — but the real test is whether the moderation in cigarette declines persists as enforcement and consumer fatigue continue to reshape the nicotine landscape.